Investigation of the Use of Hyperspectral Imaging in Foot Surgery Patients

Status Withdrawn

Clinical Trial Summary

To investigate novel advanced imaging techniques (hyperspectral imaging) that could enable clinicians to determine the degree and effectiveness of blood flow to tissues during surgery.

There are a number of disorders where blood flow is inadequate to provide nutrients and oxygen to tissues. Under some circumstances, surgery is required to either improve the blood flow or remove tissues that are poorly perfused. In other cases, occlusion of the blood supply to an organ is temporarily or permanently performed to minimize blood loss during a surgical procedure.

Additionally, there are disorders where the location of certain blood containing structures is important but not immediately obvious to surgeons during an operation. Knowledge of where those structures are is very important and could greatly improve the safety of various surgical procedures.

Patients of the investigator who are scheduled for foot surgery will be provided the opportunity to participate in this research. After giving informed consent, hyperspectral images will be obtained at various points during the surgical procedure.

As this technology is non-invasive, it is not expected to interfere with or change the procedure they are undergoing. Once the surgical procedure is complete, imaging will be saved to a disk for later evaluation.

100 subjects will participate in this study.

Clinical Trial Description

The hyperspectral imager will be turned on at various time points during surgery, to measure the spectral wavelengths of tissues. The surgery being performed will in no way be altered by the imaging device and post surgical follow-up of patients will be standard of care appropriate to the surgical procedure.

Patients will have HSI performed only during their surgery. They will not receive additional medications and will have no additional follow up. Participating in this study will not add extra appointments, procedures, or time requirements for the patient. The patient's medical record may be referenced for information after the surgery for up to one year. There are no costs to the patient for participation in this study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03787862
Study type	Observational
Source	University of Texas Southwestern Medical Center
Contact
Status	Withdrawn
Phase
Start date	June 13, 2014
Completion date	June 13, 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03947450` - Autologous Volar Fibroblast Injection Into the Stump Site of Amputees	Phase 2
Completed	`NCT04924036` - Qbrexza Cloths for Hyperhidrosis of Amputation Sites	Phase 2
Recruiting	`NCT04839497` - Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.	Phase 2
Recruiting	`NCT04212299` - Transfemoral Socket Design and Muscle Function	N/A
Completed	`NCT03733054` - Understanding Prosthetic Needs and Outcomes in Women Veterans With Amputation
Completed	`NCT03651830` - A Test-Drive Strategy for the Prescription of Prosthetic Feet for People With Leg Amputations	N/A
Recruiting	`NCT04725006` - Sensory Responses to Dorsal Root Stimulation	N/A
Not yet recruiting	`NCT06007885` - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.	N/A
Not yet recruiting	`NCT04936789` - Clinical Feasibility of the IMES Transradial Prosthesis	N/A
Completed	`NCT01155024` - Clinical Evaluation of Direct Manufactured Prosthetic Sockets	Phase 2
Completed	`NCT00663663` - Telephone Intervention for Pain Study (TIPS)	N/A
Terminated	`NCT00778856` - Hand Transplantation for the Reconstruction of Below the Elbow Amputations	N/A
Recruiting	`NCT00388752` - Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation	Phase 1
Active, not recruiting	`NCT03374319` - Somatotopic Configuration of Distal Residual Limb Tissues in Lower Extremity Amputations	N/A
Completed	`NCT05542901` - Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees	N/A
Completed	`NCT05161364` - Kinetic Analysis Due to Foot Dysfunction
Recruiting	`NCT06194838` - Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees	N/A
Completed	`NCT03570788` - HRQoL Among Patients Amputated Due to Peripheral Arterial Disease
Completed	`NCT05778799` - Physical Activity and Sports for People With Special Needs
Recruiting	`NCT04804150` - Daily Socket Comfort in Transtibial Amputee With an Active Vacuum Suspension System	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Investigation of the Use of Hyperspectral Imaging in Foot Surgery Patients — HSI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms